Wuqinxi

1. Wuqinxi decreases low-density lipoprotein in humans (SMD = -0.63, 95% CI: -1.19 to -0.07).

   Reviewin middle-aged and older adults with primary hypertension3-6 months

   Effects of Wuqinxi on blood pressure and lipids in hypertensive middle-aged and elderly adults: a meta-analysis · Frontiers in medicine · 1 Sep 2026

Low-density lipoprotein →

1. Wuqinxi increases high-density lipoprotein in humans (SMD = 0.71, 95% CI: 0.40-1.02).

   Reviewin middle-aged and older adults with primary hypertension3-6 months

   Effects of Wuqinxi on blood pressure and lipids in hypertensive middle-aged and elderly adults: a meta-analysis · Frontiers in medicine · 1 Sep 2026

High-density lipoprotein →

1. Wuqinxi decreases diastolic blood pressure in humans (-6.7 mmHg).

   Reviewin middle-aged and older adults with primary hypertension3-6 months

   Effects of Wuqinxi on blood pressure and lipids in hypertensive middle-aged and elderly adults: a meta-analysis · Frontiers in medicine · 1 Sep 2026

Diastolic blood pressure →

1. Wuqinxi decreases systolic blood pressure in humans (-5.3 mmHg).

   Reviewin middle-aged and older adults with primary hypertension3-6 months

   Effects of Wuqinxi on blood pressure and lipids in hypertensive middle-aged and elderly adults: a meta-analysis · Frontiers in medicine · 1 Sep 2026

Systolic blood pressure →